Lamoste, Roscia .

HRN: 25-22-68  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2025
CEFUROXIME 1.5GM (VIAL)
08/10/2025
08/11/2025
IVT
1.5g
Q8
LTCS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: